Association Between Hepatitis C Infection and Renal Cell Carcinoma

The purpose of this study is to determine if there is an association between hepatitis C infection and kidney cancer. All patients who are diagnosed with kidney cancer and who will either have a biopsy or surgery will be offered to be tested for hepatitis C. The control group will be colon cancer patients. Both groups would be of recent diagnosis (6 months).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatitis C Adenocarcinoma Blood-Borne Infections Carcinoma Carcinoma, Renal Cell Colonic Diseases Colorectal Cancer Colorectal Neoplasms Communicable Diseases Digestive System Diseases Digestive System Neoplasms Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Flaviviridae Infections Gastrointestinal Diseases Gastrointestinal Neoplasms Hepatitis Hepatitis, Viral, Human Infections Intestinal Diseases Intestinal Neoplasms Kidney Diseases Kidney Neoplasms Liver Diseases Male Urogenital Diseases Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial RNA Virus Infections Rectal Diseases Renal Cell Carcinoma Urogenital Diseases Urogenital Neoplasms Urologic Diseases Urologic Neoplasms Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Henry Ford Hospital

Detroit, Michigan, 48202, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male and female patients 18 years or older in whom renal cell carcinoma is suspected and are scheduled for either biopsy or partial or total nephrectomy. Diagnosis within 6 months.
Male and female patients 18 years or older in whom colorectal cancer has been diagnosed within the last 6 months

Exclusion criteria

Patients who are unwilling to provide consent
Patients who decline to complete a questionnaire
Patient in who blood sample cannot be obtained
Diagnosis of renal cell carcinoma or colon cancer greater than 6 months

Treatment and study plan

Hepatitis C testing

Other

Hepatitis C antibody, Hepatitis C RNA quantitative and for those who test positive Hepatitis C genotype

Primary outcomes

Prevalence of hepatitis C in renal cell carcinoma patients

Time frame: 2 years

Determine the prevalence of hepatitis C infection in newly diagnosed renal cell carcinoma patients

Sponsors and collaborators

Lead sponsor

Henry Ford Health System

Other

Collaborators

Schering-Plough

Registry information

Official study title

Association Between Hepatitis C Infection and Renal Cell Carcinoma, a Case Control Study

Important dates

Study start: 2011
Primary completion: 2013
Study completion: 2013
First posted: Jul 29, 2011
Registry last updated: Sep 17, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed